124 related articles for article (PubMed ID: 35113348)
21. Secondary Hemophagocytic Lymphohistiocytosis in a Neonate with SARS-CoV-2 Infection.
El-Isa HZ; Khader OA; Khader M; Ashour BA; Azzam MI; Badran EF
Am J Case Rep; 2022 Jan; 23():e934839. PubMed ID: 35087017
[TBL] [Abstract][Full Text] [Related]
22. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
Loscocco GG
Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
[No Abstract] [Full Text] [Related]
23. Cytokine release syndrome in severe COVID-19.
Moore JB; June CH
Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
[No Abstract] [Full Text] [Related]
24. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
Takami A
Int J Hematol; 2020 Jul; 112(1):122-124. PubMed ID: 32399895
[No Abstract] [Full Text] [Related]
25. Hemophagocytic lymphohistiocytosis after COVID-19 vaccination.
Tang LV; Hu Y
J Hematol Oncol; 2021 Jun; 14(1):87. PubMed ID: 34088334
[TBL] [Abstract][Full Text] [Related]
26. Dengue associated hemophagocytic lymphohistiocytosis: a case series.
Pal P; Giri PP; Ramanan AV
Indian Pediatr; 2014 Jun; 51(6):496-7. PubMed ID: 24986293
[TBL] [Abstract][Full Text] [Related]
27. Hemophagocytic syndrome: a potential COVID-19 complication.
Amaral LTW; Fonseca EKUN; Jacomelli M; Szarf G; Chate RC
J Bras Pneumol; 2020 Sep; 46(5):e20200296. PubMed ID: 32965311
[No Abstract] [Full Text] [Related]
28. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
Prilutskiy A; Kritselis M; Shevtsov A; Yambayev I; Vadlamudi C; Zhao Q; Kataria Y; Sarosiek SR; Lerner A; Sloan JM; Quillen K; Burks EJ
Am J Clin Pathol; 2020 Sep; 154(4):466-474. PubMed ID: 32681166
[TBL] [Abstract][Full Text] [Related]
29. A case of Hemophagocytic lymphohistiocytosis induced by COVID-19, and review of all cases reported in the literature.
Kayaaslan BU; Asilturk D; Eser F; Korkmaz M; Kucuksahin O; Pamukcuoglu M; Guner R
J Infect Dev Ctries; 2021 Nov; 15(11):1607-1614. PubMed ID: 34898486
[TBL] [Abstract][Full Text] [Related]
30. Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.
Ardern-Jones MR; Stammers M; Phan HT; Borca F; Koutalopoulou A; Teo Y; Batchelor J; Smith T; Duncombe AS
Clin Med (Lond); 2021 Sep; 21(5):e543-e547. PubMed ID: 34389636
[TBL] [Abstract][Full Text] [Related]
31. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
Dimopoulos G; de Mast Q; Markou N; Theodorakopoulou M; Komnos A; Mouktaroudi M; Netea MG; Spyridopoulos T; Verheggen RJ; Hoogerwerf J; Lachana A; van de Veerdonk FL; Giamarellos-Bourboulis EJ
Cell Host Microbe; 2020 Jul; 28(1):117-123.e1. PubMed ID: 32411313
[TBL] [Abstract][Full Text] [Related]
32. Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination.
Mungmunpuntipantip R; Wiwanitkit V
Infection; 2022 Dec; 50(6):1615. PubMed ID: 35349078
[No Abstract] [Full Text] [Related]
33. [The neurology of COVID-19].
Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
[TBL] [Abstract][Full Text] [Related]
34. Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.
Hieber ML; Sprute R; Eichenauer DA; Hallek M; Jachimowicz RD
Infection; 2022 Oct; 50(5):1399-1404. PubMed ID: 35218512
[TBL] [Abstract][Full Text] [Related]
35. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
Opoka-Winiarska V; Grywalska E; Roliński J
BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
[TBL] [Abstract][Full Text] [Related]
36. Patients presenting high fever with lymphadenopathy after COVID-19 vaccination were diagnosed with hemophagocytic lymphohistiocytosis.
Baek DW; Hwang S; Kim J; Lee JM; Cho HJ; Moon JH; Hwang N; Jeong JY; Lee SW; Sohn SK
Infect Dis (Lond); 2022 Apr; 54(4):303-307. PubMed ID: 34854350
[TBL] [Abstract][Full Text] [Related]
37. Haemophagocytic lymphohistiocytosis in pregnancy: a pertinent case during the COVID-19 pandemic.
Potts J; Gaudet B; Durie D; Quinones J
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34535494
[TBL] [Abstract][Full Text] [Related]
38. Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.
Faguer S; Del Bello A; Abravanel F; Nicolau-Travers ML; Kamar N
Ann Intern Med; 2020 Sep; 173(6):501-503. PubMed ID: 32432518
[No Abstract] [Full Text] [Related]
39. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
Schnaubelt S; Tihanyi D; Strassl R; Schmidt R; Anders S; Laggner AN; Agis H; Domanovits H
Medicine (Baltimore); 2021 Mar; 100(12):e25170. PubMed ID: 33761694
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019.
Clark KEN; Nevin WD; Mahungu T; Lachmann H; Singh A
Clin Infect Dis; 2021 Nov; 73(9):e3110-e3112. PubMed ID: 32985664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
